Search Results 1461-1470 of 20356 for hepatitis

  1. Curriculum - Transplant Hepatology Fellowship (Florida) - Mayo Clinic College of Medicine & Science

    ... hepatitis, alcoholic liver disease, autoimmune hepatitis and hepatobiliary neoplasms. You develop skills in managing complications of chronic liver disease ...

  2. Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk Myelodysplastic Syndromes - Mayo Clinic

    Known active infection with human immunodeficiency virus or hepatitis viruses. Participating Mayo Clinic locations. Study statuses change often. Please ...

  3. Medical Research & Education - Mayo Clinic News Network

    'Our goal is to achieve a world without viral hepatitis'. Joel Streed. October 1, 2021. 9-30-2021 COVID-19 Media Only News Briefing: Treatments for COVID.

  4. Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer - Mayo Clinic

    Has a known history of Hepatitis B (defined as Hepatitis B surface antigen [HBsAg] reactive) or known active Hepatitis C virus (defined as HCV RNA [qualitative] ...

  5. Nevirapine (oral route) - Side effects & dosage - Mayo Clinic

    Hepatitis B or; Hepatitis C—Use with caution. May cause side effects to become worse. Liver disease, moderate or severe—Should not be used in patients with ...

  6. A Study to Evaluate CB-839 With Radiation Therapy and Temozolomide in Treating Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma - Mayo Clinic

    If there is history of hepatitis C virus (HCV) infection, patients must have been treated and HCV viral load must be undetectable. Patient must have ...

  7. Emtricitabine, rilpivirine, and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

    Hepatitis B or C infection, history of or; Kidney failure, history of—Use with caution. May make these conditions worse. Kidney disease, end stage (who are ...

  8. Biliary atresia - Doctors and departments - Mayo Clinic

    oholic fatty liver disease, Cirrhosis, Autoimmune hepatitis, Alcoholic hepatitis, Hemochromatosis, Hepatic encephalopathy, Portal hypertension, Biliary atresia.

  9. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

    Patients who experienced a de novo or reactivated serious viral infection such as hepatitis B virus (HBV), hepatitis C virus (HCV), or HIV during Study GA29144.

  10. A Study to Evaluate Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer - Mayo Clinic

    Detectable viral infections (e.g. known HIV, known active hepatitis B or C). Participating Mayo Clinic locations. Study statuses change often. Please contact ...